Anavex regains Nasdaq compliance after delayed 10-Q filings
Anavex Life Sciences regained Nasdaq compliance after filing its delayed Form 10-Qs for March 31 and June 30, 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.